What is Medal?
Medal Inc. specializes in extracting comprehensive medical information from diverse data sources, including fax, printed paper, health information exchange data, and various electronic records. Leveraging proprietary technology, the Medal Machine Learning and Natural Language Processing system analyzes unstructured text to generate detailed clinical narratives by matching over 300 medical attributes. This advanced capability positions Medal as a leader in clinical data interpretation and analysis, based in San Francisco, CA.
How much funding has Medal raised?
Medal has raised a total of $4.1M across 2 funding rounds:
Angel/Seed
$3.8M
Debt
$350K
Angel/Seed (2016): $3.8M with participation from 8VC, Draper Associates, Founders Fund, and ZhenFund
Debt (2020): $350K led by PPP
Key Investors in Medal
8VC
8VC is a venture capital firm known for its investments in technology and innovation, likely focusing on companies with disruptive potential in sectors like healthcare technology.
Draper Associates
Draper Associates is a prominent venture capital firm with a history of backing transformative technology companies, suggesting a strategic interest in Medal's advanced AI capabilities.
Founders Fund
Founders Fund is a venture capital firm that invests in companies with significant potential to reshape industries, indicating a belief in Medal's disruptive technology and market impact.
What's next for Medal?
The recent major strategic investment, alongside the substantial total funding, indicates Medal is poised for significant scaling and market expansion. This capital infusion will likely fuel further development of its AI-driven data extraction and analysis platform, enhancing its competitive edge in the healthcare technology sector. Future initiatives may include broader integration with healthcare systems and the expansion of its client base, solidifying its role in transforming how medical information is accessed and utilized.
See full Medal company page
